with support from Alix Beith and Scott Kniaz.
I am finding it hard to choose a side on the recent malaria treatment policy debate. It is clear that current anti-malarial treatment policy -- which dictates that, in high-transmission settings, children under five that have a fever are given anti-malarials -- certainly not optimal. Children with fevers not caused by malaria may suffer side-effects from taking unnecessary anti-malarial drugs and are also not being treated for what ails them. Additionally, excessive use of anti-malarials is a driver of the emergence of drug-resistant strains of the malaria parasite, which can then be transmitted to the larger community.